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Abstract The monoclonal antibody 5a19, raised against the
ay serotype of hepatitis B virus, binds to the segment of the preS1
region comprising residues 37^43, which is implicated in
attachment of the virus to hepatocytes. The dissociation
constant, derived from kinetic studies using surface plasmon
resonance techniques, is in the low nanomolar range. The
nucleotide sequence of the variable domains has been deter-
mined and the corresponding germ-line genes have been
identified. The three-dimensional structure of the Fab fragment
has been determined by X-ray crystallography to 2.6 Aî
resolution. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Hepatitis B virus (HBV), a member of the Hepadnaviridae
family, is a major cause of chronic liver disease and is one of
the principle etiological factors associated with hepatocellular
carcinoma [1]. The infectious viral particle contains a nucleo-
capsid with icosahedral symmetry enclosing a circular, parti-
ally double-stranded DNA genome (about 3.2 kb depending
on serotype) and the P protein, which has DNA polymerase
activity. The nucleocapsid itself is enveloped by a lipid bilayer
into which are inserted three related transmembrane glycopro-
teins, S, M and L [2]. The genes encoding the three glycopro-
teins begin with distinct initiation codons, but share the same
reading frame and stop codon. Thus, the protein S, the small-
est envelope protein, is 226 amino acids in length. The protein
M, in turn, carries and additional 55 amino acid segment, the
preS2 region, in a position N-terminal to the S sequence.
Similarly, the protein L is composed of the preS1 region,
108 or 119 amino acid residues in length depending on the
serotype, positioned N-terminal to the M sequence. Two other
forms of viral particles have been characterized: the spherical
and ¢lamentous particles. Being composed of the envelope
material only (lipid and envelope glycoprotein), they are
non-infectious.
Although HBV shows a strong tropism towards hepato-
cytes, it can invade other human cell lines. Nonetheless,
only infection of the liver appears to lead to clinical pathology
for hepatitis B [3]. Diverse candidates for the viral receptor
have been proposed: the IgA receptor, glyceraldehyde-3-phos-
phate dehydrogenase, asialoglycoprotein receptor, annexin V,
and several other less well characterized proteins [3]. The re-
gion of the virus involved in attachment to the hepatocyte, on
the other hand, has been clearly identi¢ed as the preS region
of the envelope proteins. In particular, the preS1 peptide frag-
ment comprising residues 21^47 (preS1(21^47)), as well as
antibodies induced by this peptide inhibit HBV binding to
HepG2 cells [4,5], implicating this region of the L envelope
protein in the virus^host cell interaction.
The murine monoclonal antibody (mAb) 5a19 recognizes a
linear epitope preS1(36^43) [6] and inhibits invasion of cul-
tured human hepatocytes [7]. Here, we present the sequence of
the heavy and light chain variable domains (VH and VL, re-
spectively), kinetic studies of antigen-binding, and ¢ne epitope
mapping of the preS1 region recognized by 5a19. We also
describe the three-dimensional structure of the Fab fragment
of 5a19, determined by X-ray crystallography to a resolution
of 2.6 Aî .
2. Materials and methods
2.1. Preparation and puri¢cation of IgG and Fab fragments
The mAb 5a19 (isotype IgG1,U) was obtained by immunizing
BALB/c mice with HBV particles of the ay serotype [6]. The immu-
noglobulin was puri¢ed from ascitic £uid by precipitation with 40%
ammonium sulfate at pH 7.4, followed by ion-exchange chromatog-
raphy on a DEAE-Sephacel (Pharmacia) column using an increment-
ing NaCl concentration gradient (0^500 mM) in Tris bu¡er at pH 8.0.
Antibody fractions were pooled and dialyzed across a microsep 10K
(Filtron) against 0.1 M potassium phosphate at pH 7.2.
After addition of mercaptoethanol (14 mM) and EDTA (6 mM),
the IgG was treated with papain at an enzyme:substrate ratio of 1:300
at 37‡C for 2 h. After incubating with 20 mM iodoacetamide for 30
min at room temperature, the bu¡er was changed to 0.02 M potas-
sium phosphate at pH 7.8. The protein was then added to a DEAE-
Sephacel (Pharmacia) column equilibrated with the same bu¡er. Fab
5a19 was eluted by the running phosphate bu¡er.
2.2. Epitope mapping
Peptides bound to cellulose were prepared by automated synthesis
(SPOTs, Genosys Biotechnologies, Cambridge, UK). The cellulose
membranes were treated overnight at 4‡C with a blocking agent (sup-
plied by the manufacturer) placed in Tris-bu¡ered saline (50 mM
Tris^HCl at pH 7.6, 150 mM NaCl) and 0.05% Tween 20, with 5%
sucrose. After washing with Tween/Tris-bu¡ered saline (T-TBS), the
membranes were incubated for 1 h at room temperature with IgG
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5a19 (1 Wg/ml in blocking bu¡er). After extensive washing in T-TBS,
the membranes were then incubated for 1 h with a 1:5000 dilution of
peroxidase-conjugated sheep anti-mouse IgG, H+L (ICN). Following
a ¢nal wash with T-TBS, ECL detection reagent was added for 30 s
before exposing to Hyper¢lm (Amersham).
2.3. Kinetic analysis of 5a19-binding
The association (kon) and dissociation (koff ) rate constants were
measured by surface plasmon resonance using a BIAcore 2000 instru-
ment (BIAcore AB, Uppsala, Sweden). Two series of experiments
were performed, one in which the antigenic peptide was ¢xed to the
sensor chip, and the other where IgG 5a19 was ¢xed.
1. Sensor-¢xed antigen: the biotinylated peptide preS1(21^48) was
immobilized on a streptavidin-coated SA chip (BIAcore AB) and
the Fab 5a19 was used as the analyte. Association and dissociation
rate constants of the analyte were measured at 25‡C using Fab
concentrations ranging from 0.01 to 1 WM in HBS-EP bu¡er (10
mM HEPES pH 7.4, 150 mM NaCl, 3 mM EDTA and 0.005%
Tween 20), and a £ow rate of 50 Wl/min.
2. Sensor-¢xed antibody: IgG 5a19 was immobilized on the sensor
chip and the biotinylated peptide preS1(21^48) was used as the
analyte. The antibody was covalently ¢xed to a CM5 chip by its
primary amine groups using an amine-coupling kit (BIAcore AB).
IgG 5a19 was then injected at a concentration of 30 Wg/ml in 10
mM sodium acetate at pH 5.0. The immobilization procedure was
completed by a 35 Wl injection of 1 M ethanolamine/HCl mixture
at pH 8.5 to block remaining active groups present on the matrix.
To avoid potential e¡ects of mass transport, kinetic measurements
were made with the biotinylated peptide at low concentrations,
ranging from 1 pM to 100 WM, in a HBS-EP bu¡er and with a
£ow rate of 50 Wl/min at 25‡C.
In both series of measurements, the chip was regenerated by a 30 s
injection pulse with 10 mM HCl, and one background surface on the
chip was retained for control runs. Kinetic constants were derived
with the BIAEVALUATION 3.01 software (BIAcore AB), ¢tting
kon and koff separately, and using background-subtracted sensor-
grams.
2.4. Sequencing of the variable domains of 5a19
Total RNA was extracted from about 107 5a19 hybridoma cells by
guanidinium thiocyanate extraction using Tri reagent (Sigma). The
RNA was used as substrate for cDNA synthesis using an oligo-dT
15-mer primer (Roche Molecular Biochemicals) and Moloney murine
leukemia reverse transcriptase (Gibco BRL). cDNA for the VU do-
main was ampli¢ed by PCR using LC7 (5P-CCA GGT CCG AGC
TCG TGA TGA CAC AGT CTC CA-3P) and CU_2 (5P-GAT GGA
TAC AGT TGG TGC AGC ATC AGC CCG-3P) primers. The VH
domain was ampli¢ed with the primers VHIIID (5P-GAA GTG CAG
CTC GAG GAG TCT GGG GG-3P) and CH (5P-GGC AGC GAT
CCA GGG GCC AGT GG-3P). The PCR products were cloned and
each sequence was analyzed from at least three di¡erent colonies.
2.5. Crystallization and di¡raction data collection
Crystals of Fab 5a19 were grown by vapor di¡usion using the
hanging drop technique. A volume of 2 Wl of protein was mixed
with 0.5 Wl of 0.1 M cysteine and 0.5 Wl of bu¡er containing 15%
(w/v) PEG 6000, 110 mM MgCl2, 60 mM Tris^HCl, pH 8.5, and 15%
glycerol. The drop, with a ¢nal protein concentration of 4.7 mg/ml,
was sealed over a reservoir containing 1 ml of bu¡er. The crystals,
which appeared after 1^2 weeks at 17‡C, belong to the space group
P212121 with unit cell parameters a = 47.01 Aî , b = 88.46 Aî , c = 111.67
Aî . The unit cell volume is consistent with one Fab molecule in the
asymmetric unit.
Di¡raction data were collected at the beam line D41 at LURE
using a MarResearch imaging plate detector (18 cm diameter). A
complete data set to 2.6 Aî resolution was obtained from single crystal
at ambient temperature using a monochromated X-ray wavelength of
1.375 Aî . Di¡raction intensities were integrated with the programme
HKL [8], yielding a total of 14823 unique re£ections (Rmerge = 7.7%,
redundancy = 6.5).
2.6. Determination and re¢nement of the structure
A preliminary model of Fab 5a19 was obtained by molecular re-
placement using the programme AmoRe [9]. A variable domain dimer
(VL/VH) and a constant domain dimer (CL/CH1), obtained from Pro-
tein Data Bank (PDB) entries 1hil and 1fdl, respectively, were used as
independent search models in the rotation and one-body translation
functions. A two-body translation search assembled the independently
determined solutions for the (VL/VH) and (CL/CH1) dimers to give a
sensible pairing of the light and heavy chains within the single Fab
fragment present in the asymmetric unit, thus con¢rming the correct-
ness of the rotation and translation function results. In addition, the
molecular packing of the model in the unit cell was free of steric
hindrance. The position and orientation of the variable and constant
domain dimers were optimized by rigid-body re¢nement. After intro-
ducing the derived 5a19 sequence into the molecular replacement
model, re¢nement of the atomic parameters was carried out with
the programme X-PLOR [10] using data between the resolution limits
15.0 and 2.6 Aî (5% of these data were randomly selected for calculat-
ing Rfree). Bulk solvent corrections were applied using the procedure
described by Jiang and Bru«nger [11].
3. Results and discussion
3.1. Epitope mapping
Peptide fragments contained within the segment preS1(31^
47) from the ay serotype were synthesized to perform epitope
mapping using the SPOTs system. The results of this analysis
Fig. 1. Epitope mapping of 5a19 using the SPOTs test. The intensity
of the spot indicates the avidity of the antibody. (a) Recognition of
6^15-mer peptides spanning the sequence 31^47 of the preS1 region
(ay serotype). (b) The speci¢city of 5a19 was examined by substitu-
tion of each serotype-dependent residue by the one corresponding
to the ad serotype (Gly35, Ser38, Asn39). See Section 3 for other
mutations made at positions 36, 38 and 39.
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are visualized in Fig. 1. The patterns of recognition by 5a19 of
peptides truncated from the N- and C-termini indicate that
the minimum epitope is the segment preS1(37^43). Alanine
scanning across this seven-residue segment showed no signi¢-
cant e¡ect on the ability of 5a19 to recognize the epitope
(data not shown). The substitutions Arg35CGly, Thr38CSer
and Ala39CAsn, corresponding to changes to the ad sero-
type, were also tried separately, but only the substitution at
position 39 showed a reduction in recognition, consistent with
the previously reported preference of 5a19 for the ay serotype
[6].
The sensitivity to di¡erent residue types was further probed
at positions 36, 38 and 39. The substitution Ala36CAsp, but
not Ala36CAsn, reduces 5a19-binding. Substitution of Thr38
by the polar residues Asp, His and Asn showed a reduction in
recognition. Substitution with Ser, Ala, Leu or Val, by con-
trast, showed no di¡erence with respect to the native se-
quence, showing that hydrophobic residues of di¡erent size
produced no observable e¡ect on the binding of 5a19.
Changes in reactivity to substitutions at Ala39 were sensitive
to charge since either reduced binding, or none at all, was
observed when this residue was replaced by His or Asp. Size
of the side chain of residue 39 seems critical since reactivity is
lost by substitution with Leu, but is observable if replaced by
Val or Ser. Residue W43 was also tested by substitutions with
Asp and His, but no di¡erence with respect to wild-type ay
antigen was observed (data not shown).
3.2. Kinetic analysis of 5a19-binding
1. Immobilized biotinylated preS1(21^48) using Fab 5a19 as
analyte: the monovalent Fab fragment of 5a19 was used
instead of the bivalent IgG molecule to avoid potential
artefacts arising from avidity. The net surface resonance
signal after addition of the biotinylated preS1(21^48) pep-
tide was 25 RU (resonance units ^ 1 RU = 1 pg/mm2) and
the kinetic constants were calculated by ¢tting a simple
bimolecular reaction model to the data. The averaged val-
ues for kon and koff were 1.2 ( þ 0.6)U105 M31 s31 and 1.9
( þ 0.3)U1034 s31, respectively, giving an estimated a⁄nity
constant (KD = koff /kon) of 1.6 ( þ 0.8)U1039 M.
2. Immobilized antibody using biotinylated preS1(21^48) as
analyte: mAb 5a19 was immobilized on the CM5 sensor
chip surface at a level of 4600 RU. The analyte concentra-
tions used were 5, 10, 50, 100 nM, corresponding to a
response of 10^85 RU and the kinetic constants were
also calculated from the data by assuming a simple bimo-
lecular reaction. The averaged values for kon and koff were
5.8 ( þ 1.2)U104 M31 s31 and 2.7 ( þ 0.2)U1034 s31, re-
spectively, giving an estimated dissociation constant of
4.6 ( þ 1.0)U1039 M.
Although the estimates of KD were obtained from two in-
dependent experimental procedures, they di¡er by less than
three standard deviations, the major di¡erence arising from
the values of kon. Reasons for this di¡erence are di⁄cult to
identify, but may be related to the di¡erent kinetic behavior of
the analyte in each case.
3.3. Sequence of the variable domains of 5a19
The variable domain sequences of 5a19 are given in Fig. 2.
VL is derived from the VU8-21 germ-line sequence [12], having
a total of nine nucleotide changes due to somatic mutation,
three of which are silent. This leads to the following changes
in the amino acid sequence: Ala15CVal, Lys24CArg,
Ser27CThr, Tyr36CPhe, Leu46CLeu and Asn93CSer.
The framework region FR4, encoded by the JU2 gene, has
not been subjected to somatic mutations. Although no
germ-line gene for VH could be found, a 96.9% sequence iden-
tity occurs with the VH domain of the IgM D2 [13], which
belongs to the VH7183 gene family. Of the seven nucleotide
changes, two are silent and the remaining ¢ve give rise to the
amino acid changes Ile51CVal, Gly53CAsp, Thr57CAla,
Val63CLeu and Arg94CSer. These probably re£ect real
germ-line changes since IgM immunoglobulins are rarely sub-
ject to somatic hypermutation. The CDR-H3 and FR4 regions
of VH are encoded by the DQ52 (used in the second reading
frame) and JH3 minigenes, respectively, with some nucleotide
deletions and additions occurring at the junctions.
The VH and VL nucleotide sequences have been deposited
in the EMBL nucleotide sequence database with accession
numbers AJ344367 and AJ344368, respectively.
3.4. Structure of 5a19
After completion of the re¢nement of the atomic parame-
ters, the R and Rfree values were 0.213 and 0.291, respectively,
for a model comprising 3347 protein atoms and 132 solvent
positions. The average protein temperature factor is 35.4 Aî 2,
and the root mean square deviation from ideal bond length
and angles is 0.005 Aî and 1.2‡, respectively. Coordinates have
been deposited in the PDB with entry code 1gm3.
The main chain of 5a19 could be traced without ambiguity
for both the H and L chains, except for the region H128^
H133, and the two C-terminal regions L212^L214 and
H214^H215; these regions were not included in the ¢nal mod-
el. The side chain of Trp-H97, belonging to CDR-H3, had ill-
de¢ned electron density but was modelled as two discrete con-
formers. A total of 98.7% of the residues have main-chain
conformation angles (B^i) falling within the favored region
of the Ramachandran plot (as de¢ned by the programme
PROCHECK [14]). Residue Ala-L51 forms part of a Q-turn
characteristic of the unique canonical conformation of CDR-
L2, and thus falls in an energetically unfavored region of the
main-chain (B^i) plot. Residues contributed by all six CDRs
of Fab 5a19 make extensive contacts with a neighboring mol-
ecule, burying a total surface of 938 Aî 2 from the solvent, thus
precluding di¡usion of the peptide ligand through the crystal
lattice to the antigen-binding site.
The hypervariable regions CDR-L1, CDR-L2, CDR-H1
and CDR-H2 conform to the canonical conformations
[15,16], belonging to the classi¢cations 3 (17 residues), 1 (sev-
en residues), 1 (¢ve residues) and 3 (six residues), respectively
(CDR lengths used are those de¢ned in [15]). CDR-L3 has
residue 95 deleted to give a hypervariable region of eight
amino acids. This is due to a codon loss when the VL and
J gene segments were joined during somatic recombination.
Although there is no accepted canonical classi¢cation to de-
scribe the CDR-L3 structure of 5a19, its conformation is the
same as that observed in the anti-CD25 mAb CRIS [17] and
the catalytic antibody 17E8 [18]. CDR-H3 is seven residues in
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Fig. 2. Nucleotide and amino acid sequences for the variable domain of 5a19. The amino acid residue numbering and CDR limits are accord-
ing to [20]. Di¡erences with germ-line sequences and the corresponding amino acid sequences are shown. N-terminal residues falling in regions
covered by the primers were identi¢ed by amino acid sequencing. (a) 5a19 VL domain is compared with VU8-21 germ-line (GenBank entry
Y15982). FR4 is compared with JU2. (b) 5a19 VH domain is compared with IgM D2 [13] (GenBank entry M83724). CDR-H3 and FR4 are
compared with DQ52 and JH3 gene segments.
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length and is thus slightly shorter than the mean length of 8.7
residues noted by Wu et al. [19].
Hypermutation has introduced changes in the germ-line se-
quence that a¡ect the antigen-binding site. The VU gene
presents two changes in CDR-L1 (residues L24 and L27E)
and one change in CDR-L3 (residue 93). VH gene changes
occur in CDR-H2 (residue H53) and CDR-H3 (residue
H94), although the latter change could have arisen from the
V-D recombination joining event rather than the latter so-
matic recombination event (see Fig. 2). Only Ser-L93 and
Asp-H53, however, are favorably located in the antigen-bind-
ing site to form potential contacts to the antigen.
The antigen-binding site of 5a19 takes the form of a groove
of length 27 Aî , width 20 Aî and depth 15 Aî . The electrostatic
potential (Fig. 3) is signi¢cantly negative in the groove, but
with an important positive contribution on the side from
CDR-L1. The groove-like topology, rare in anti-protein anti-
bodies, is more reminiscent of that found in anti-peptide anti-
bodies and would be consistent with the recognition by 5a19
of a linear epitope in the preS1 region. We are attempting to
co-crystallize Fab 5a19 with peptide fragments containing the
minimal epitope determined by our studies reported here to
understand the nature of the interaction of 5a19 with the viral
antigen.
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